Back to search results

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Conditions

Peripheral Neuropathy Due to Chemotherapy · Peripheral Neuropathy · Neurotoxicity Syndromes · Neuropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Ka-Wai Ho, MD) · kho5@bidmc.harvard.edu · 617-667-1665
    Contact: Principal Investigator (Ka-Wai Ho, MD)

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Tamar Berger, MD, PhD) · Tamar_berger@dfci.harvard.edu · 617-632-6140
    Contact: Principal Investigator (Tamar Berger, MD, PhD)
Study leads

  • Ka-Wai Ho, MD

    Principal Investigator

    Beth Israel Deaconess Medical Center

  • Tamar Berger, MD PhD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)